" class="no-js "lang="en-US"> Lannett - Medtech Alert
Thursday, April 18, 2024
Lannett | Pharmtech Focus

Lannett

About Lannett

Lannett

Founded in 1942, Lannett Company, Inc. is a leading manufacturer of over 100 unique pharmaceutical product families that save and enhance people’s lives. With facilities in Pennsylvania, Indiana, and New York, Lannett Company, Inc. manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Our portfolio consists of numerous products across a wide range of therapeutic areas.

We believe that our ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate ourselves into certain specialty markets, and achieve economies in production are all critical for our success in the generic pharmaceutical industry in which we operate.

Having cultivated strong and dependable customer relationships by maintaining adequate inventory levels and demonstrating a responsive order filling system, we take pride in our ability to satisfy our customer’s needs. Our dedicated employees strive to position Lannett as an industry leader that is focused on quality and integrity, as well as giving back to the community we serve. Lannett has a history of supporting schools, hospitals, veterans, and their families, institutions, rehabilitation centers, cancer research, as well as the local fire and police departments.

Related Story

Lannett Announces Submission of Investigational New Drug (IND) Application for Biosimilar Insulin Glargine

December 20 2021

Lannett Company, Inc. (NYSE: LCI) today announced the submission of an Investigational New Drug (IND) application […]